Literature DB >> 12680800

Patients' vehicle preference for corticosteroid treatments of scalp psoriasis.

Steven R Feldman1, Tamara S Housman.   

Abstract

Topical therapy is one of the foundations of dermatology. The vehicles used to deliver topical therapy have considerable impact on efficacy. The vehicle can have direct effects on disease; it can impact the delivery of the active drug, and its characteristics affect patient compliance. While the physical chemistry of vehicles has been studied in great detail, there has been very little study of patients' preferences for different vehicles and even less on the effect of these preferences on patient compliance. Such study is essential, as noncompliance with topical therapy is very common, and likely impacts the response to topical therapy observed in clinical practice. This manuscript discusses information on patients' preferences for different vehicles, focussing on the treatment of scalp psoriasis. Significant vehicle characteristics such as ease or difficulty of use, messiness, odors, and staining are recognized to affect patients' preferences. An instrument based on these characteristics has been used to compare patients' preferences for different vehicles. Patients with psoriasis generally prefer less messy vehicles, such as foam and solution preparations, to traditional cream and ointment vehicles. These preferences have the potential to impact patient compliance. Studies directly measuring patient compliance have not yet been performed. In conclusion, the choice of vehicles impacts both the potency of the medication and patients' acceptance of the treatment. Actual effects of different vehicles on compliance are important but have not yet been adequately studied.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680800     DOI: 10.2165/00128071-200304040-00001

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  11 in total

Review 1.  [Calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis. A review].

Authors:  M A Radtke; K Herberger; T Kornek; M Augustin
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

2.  Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas.

Authors:  Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

3.  A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.

Authors:  T A Luger; F Cambazard; F G Larsen; M Bourcier; G Gupta; F Clonier; P Kidson; N H Shear
Journal:  Dermatology       Date:  2008-09-12       Impact factor: 5.366

Review 4.  Relative efficacy and interchangeability ofvarious clobetasol propionate vehicles in the management of steroid-responsive dermatoses.

Authors:  Steven R Feldman
Journal:  Curr Ther Res Clin Exp       Date:  2005-05

5.  Treatment of scalp and facial seborrheic dermatitis with desonide hydrogel 0.05%.

Authors:  Leon H Kircik
Journal:  J Clin Aesthet Dermatol       Date:  2009-02

6.  [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].

Authors:  T Ruzicka; C Trompke
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751

Review 7.  Topical treatments for scalp psoriasis.

Authors:  Richard B Warren; Benjamin C Brown; Christopher E M Griffiths
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam.

Authors:  Omar Pacha; Adelaide A Hebert
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-05-07

9.  Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature.

Authors:  Andreas Pinter; Henrik Thormann; Flavia Angeletti; Ahmad Jalili
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-10-09

10.  General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach.

Authors:  Diamant Thaçi; Pablo de la Cueva; Andrew E Pink; Ahmad Jalili; Siegfried Segaert; Kasper F Hjuler; Piergiacomo Calzavara-Pinton
Journal:  BJGP Open       Date:  2020-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.